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Expression of soluble scFvs in E. coliToxin composition of N. melanoleuca venom
Selection of high-affinity antibodies using       
scFv displaying phages
Antibody-mixtures may protect against 
envenoming by targeting several toxins
Naja melanoleucaRecombinant antivenom – a new hope!
Snakebite envenoming represents a major health threat in
tropical parts of the developing world1. Animal-derived
antisera currently constitute the only effective treatment option,
but are associated with severe side effects due to
incompatibility with the human immune system2. We aim at
discovering human antibodies that target the medically most
important toxins from N. melanoleuca venom using phage
display technology.
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IgGs against black cobra neurotoxins
We hope to discover human scFvs against medically
important neurotoxins from N. melanoleuca. These may be
converted to human IgGs for prolonged protection against
systemic neurotoxicity in human snakebite victims.
This may help bring recombinant antivenoms with higher
efficacy and fewer side effects to the market!
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3FTx: Three-finger toxins
PLA2: Phospholipases A2
SVMP : Snake venom metalloproteinases
CRISP: Cysteine-rich secretory protein
KUN : Bovine pancreatic trypsin inhibitors
/Kunitz-type inhibitors
FMO: Flavin monoamine oxidases
CELF: Type-B carboxylesterases/lipases
PDE: Phosphodiesterases
GPF: Glutathione peroxidases
OHA: Ohanin/vespryn
NGF: Nerve growth factors
DRE: DNA/RNA non specific_endonucleases
SUSHI: Selectins
UNK: Unknown proteins
